[go: up one dir, main page]

BRPI1011857A2 - combinações de clados rrgb pneumocócico - Google Patents

combinações de clados rrgb pneumocócico

Info

Publication number
BRPI1011857A2
BRPI1011857A2 BRPI1011857A BRPI1011857A BRPI1011857A2 BR PI1011857 A2 BRPI1011857 A2 BR PI1011857A2 BR PI1011857 A BRPI1011857 A BR PI1011857A BR PI1011857 A BRPI1011857 A BR PI1011857A BR PI1011857 A2 BRPI1011857 A2 BR PI1011857A2
Authority
BR
Brazil
Prior art keywords
pneumococcal
combinations
rrgb
rrgb clade
clade combinations
Prior art date
Application number
BRPI1011857A
Other languages
English (en)
Inventor
Michèle Barocchi
Monica Moschioni
Paolo Ruggiero
Vega Masignani
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI1011857A2 publication Critical patent/BRPI1011857A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI1011857A 2009-06-01 2010-06-01 combinações de clados rrgb pneumocócico BRPI1011857A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21762909P 2009-06-01 2009-06-01
US25442609P 2009-10-23 2009-10-23
US31420310P 2010-03-16 2010-03-16
US31892610P 2010-03-30 2010-03-30
PCT/IB2010/052445 WO2010140119A1 (en) 2009-06-01 2010-06-01 COMBINATIONS OF PNEUMOCOCCAL RrgB CLADES

Publications (1)

Publication Number Publication Date
BRPI1011857A2 true BRPI1011857A2 (pt) 2016-03-29

Family

ID=42557471

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1011857A BRPI1011857A2 (pt) 2009-06-01 2010-06-01 combinações de clados rrgb pneumocócico

Country Status (16)

Country Link
US (2) US8609106B2 (pt)
EP (1) EP2437777B1 (pt)
JP (2) JP6008741B2 (pt)
KR (1) KR20120035168A (pt)
CN (1) CN102481354A (pt)
AU (1) AU2010255356A1 (pt)
BR (1) BRPI1011857A2 (pt)
CA (1) CA2764022A1 (pt)
CO (1) CO6470864A2 (pt)
ES (1) ES2531115T3 (pt)
IL (1) IL216696A0 (pt)
MX (1) MX2011012854A (pt)
RU (1) RU2011154363A (pt)
SG (1) SG176285A1 (pt)
WO (1) WO2010140119A1 (pt)
ZA (1) ZA201109046B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011027222A2 (en) 2009-09-02 2011-03-10 Novartis Ag Immunogenic compositions including tlr activity modulators
KR20120081587A (ko) * 2009-09-10 2012-07-19 노파르티스 아게 기도 질병에 대한 조합 백신
EP2719395A1 (en) 2010-09-01 2014-04-16 Novartis AG Adsorption of immunopotentiators to insoluble metal salts
WO2012072769A1 (en) * 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
US9618508B2 (en) 2010-12-14 2017-04-11 Glaxosmithkline Biologicals Sa Flow cytometry analysis of materials adsorbed to metal salts
WO2012117377A1 (en) 2011-03-02 2012-09-07 Novartis Ag Combination vaccines with lower doses of antigen and/or adjuvant
US20140072622A1 (en) 2011-05-17 2014-03-13 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
WO2013131983A1 (en) 2012-03-07 2013-09-12 Novartis Ag Adjuvanted formulations of streptococcus pneumoniae antigens
ES2597755T3 (es) 2012-03-07 2017-01-20 Glaxosmithkline Biologicals Sa Sales de arginina de un agonista de TLR7
CA2866406A1 (en) 2012-03-08 2013-09-12 Novartis Ag Adjuvanted formulations of booster vaccines
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637481A (en) * 1993-02-01 1997-06-10 Bristol-Myers Squibb Company Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
US20010016200A1 (en) * 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
CN1972958B (zh) * 2004-04-12 2013-01-23 美国政府卫生与公共服务部 应用腺病毒载体诱导免疫应答的方法
CA2575548A1 (en) * 2004-07-29 2006-07-27 John L. Telford Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
EP1845376A4 (en) * 2005-01-28 2008-07-09 Shionogi & Co QUANTITATIVE MEASURING PROCEDURE FOR RECOMBINANT PROTEIN
WO2007116322A2 (en) * 2006-02-17 2007-10-18 Novartis Ag Purification of bacterial antigens
US20100150943A1 (en) * 2006-07-26 2010-06-17 Novartis Ag Immunogenic compositions for gram positive bacteria
PT2121011E (pt) * 2006-12-06 2014-07-31 Novartis Ag Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
GB0714963D0 (en) * 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
MX2010004850A (es) * 2007-11-02 2010-12-07 Univ Johns Hopkins Composiciones de peptidos de hpv de tipos multiples y metodos para tratamiento o prevencion de infeccion de virus de papiloma humano.

Also Published As

Publication number Publication date
US20120076814A1 (en) 2012-03-29
RU2011154363A (ru) 2013-07-20
JP2015227376A (ja) 2015-12-17
EP2437777A1 (en) 2012-04-11
IL216696A0 (en) 2012-02-29
KR20120035168A (ko) 2012-04-13
JP6008741B2 (ja) 2016-10-19
JP2012528848A (ja) 2012-11-15
ZA201109046B (en) 2013-05-29
AU2010255356A1 (en) 2011-12-22
SG176285A1 (en) 2012-01-30
WO2010140119A1 (en) 2010-12-09
EP2437777B1 (en) 2014-09-17
MX2011012854A (es) 2011-12-16
CO6470864A2 (es) 2012-06-29
CN102481354A (zh) 2012-05-30
US8609106B2 (en) 2013-12-17
CA2764022A1 (en) 2010-12-09
US20110020385A1 (en) 2011-01-27
ES2531115T3 (es) 2015-03-10

Similar Documents

Publication Publication Date Title
IL252193A0 (en) Greenhouse
BRPI1011857A2 (pt) combinações de clados rrgb pneumocócico
EP2497655A4 (en) TIRES
EP2498885A4 (en) TOY KREISEL
BRPI1013989A2 (pt) pneumático
BRPI1011967A2 (pt) pneumático
DE112010002949A5 (de) Kupplungstastpunkte
BRPI1008827A2 (pt) deisobutenizador
BRPI1014968A2 (pt) subalargador
DE112010002728A5 (de) Turboinhalator
EP2423004A4 (en) TIRE
UA21012S (uk) Іграшка
DE112010004249A5 (de) Spindelaktor
EP2289713A4 (en) TIRE
DE112009005323A5 (de) Hebelarmprüfmaschine
BRPI1008070A2 (pt) tricianoboratos
BR112012004964A2 (pt) girocóptero
FI20105110A7 (fi) Refraktometri
EP2578812A4 (en) STEAM VALVE
BRPI1008662A2 (pt) pneumático
EP2418102A4 (en) TIRE
BRPI1007486A2 (pt) pneumático
BRPI1010159A2 (pt) bistuti
BR112012003616A2 (pt) metilpirroloprimidinacarboxamidas
DE112010002351A5 (de) Klemmorrichtung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.